United Capital Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$576K Sell
34,372
-744
-2% -$12.5K ﹤0.01% 736
2025
Q1
$540K Buy
35,116
+1,833
+6% +$28.2K ﹤0.01% 720
2024
Q4
$734K Buy
33,283
+265
+0.8% +$5.84K 0.01% 619
2024
Q3
$595K Sell
33,018
-4,513
-12% -$81.3K ﹤0.01% 684
2024
Q2
$610K Sell
37,531
-1,075
-3% -$17.5K 0.01% 648
2024
Q1
$545K Buy
+38,606
New +$545K ﹤0.01% 712
2020
Q2
Sell
-13,116
Closed -$118K 1251
2020
Q1
$118K Buy
13,116
+1,484
+13% +$13.4K ﹤0.01% 1111
2019
Q4
$114K Buy
11,632
+240
+2% +$2.35K ﹤0.01% 1305
2019
Q3
$78K Buy
+11,392
New +$78K ﹤0.01% 1239
2017
Q4
Sell
-15,788
Closed -$278K 1356
2017
Q3
$278K Sell
15,788
-9,341
-37% -$164K ﹤0.01% 1136
2017
Q2
$835K Sell
25,129
-964
-4% -$32K 0.01% 811
2017
Q1
$837K Sell
26,093
-932
-3% -$29.9K 0.01% 794
2016
Q4
$980K Sell
27,025
-5,351
-17% -$194K 0.01% 758
2016
Q3
$1.49M Sell
32,376
-4,142
-11% -$191K 0.01% 666
2016
Q2
$1.83M Sell
36,518
-58,420
-62% -$2.92M 0.02% 574
2016
Q1
$5.08M Buy
94,938
+58,149
+158% +$3.11M 0.06% 329
2015
Q4
$2.42M Sell
36,789
-20,812
-36% -$1.37M 0.03% 513
2015
Q3
$3.25M Buy
57,601
+1,834
+3% +$104K 0.04% 413
2015
Q2
$3.3M Buy
55,767
+1,129
+2% +$66.7K 0.04% 458
2015
Q1
$3.3M Buy
54,638
+11,771
+27% +$711K 0.04% 440
2014
Q4
$2.47M Buy
42,867
+32,996
+334% +$1.9M 0.04% 414
2014
Q3
$531K Buy
+9,871
New +$531K 0.01% 776
2014
Q2
Sell
-10,445
Closed -$552K 918
2014
Q1
$552K Buy
10,445
+3,657
+54% +$193K 0.01% 617
2013
Q4
$272K Sell
6,788
-19,167
-74% -$768K 0.01% 543
2013
Q3
$981K Sell
25,955
-43,132
-62% -$1.63M 0.03% 347
2013
Q2
$2.71M Buy
+69,087
New +$2.71M 0.07% 270